Obstructive Sleep Apnea: Clinical Trials

12 trials for Obstructive Sleep Apnea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 terminated. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Terminated 12

Follow Obstructive Sleep Apnea: new trials by email Literature Review of Obstructive Sleep Apnea trials Research Report on Obstructive Sleep Apnea

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY.
CPAP, Nasal Strips - Obstructive Sleep Apnea, Pulmonary Edema Cardiac Cause
Phase 4TerminatedUniversity of Sao Paulo1502019-04-012024-06-07
Evaluation of Modafinil vs Placebo for Treatment of Anesthesia Delayed Emergence in Obstructive Sleep Apnea
Modafinil, Placebo - Obstructive Sleep Apnea, Delayed Emergence From Anesthesia
Phase 4TerminatedMilton S. Hershey Medical Center1052016-02-012019-06-20
InspireĀ® Upper Airway Stimulation System
InspireĀ® Upper Airway Stimulation (UAS) System - Obstructive Sleep Apnea
Phase 4TerminatedInspire Medical Systems, Inc.162015-08-012016-08-11
The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation
Normal Saline, Dexmedetomidine - Adenotonsillar Hypertrophy, Obstructive Sleep Apnea
Phase 4TerminatedMassachusetts Eye and Ear Infirmary922015-03-012020-04-09
Post-operative Pain Control After Pediatric Adenotonsillectomy
Ibuprofen, Hydrocodone-Acetaminophen - Recurrent Tonsillitis, Obstructive Sleep Apnea
Phase 4TerminatedEmory University452014-11-012018-04-25
Intermittent Hypoxia 2: Cardiovascular and Metabolism
Placebo, Valsartan, Amlodipine - Hypoxia, Sleep Apnea
Phase 4TerminatedUniversity Hospital, Grenoble122013-08-072018-12-31
Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease
Inhaled Fluticasone Propionate - Asthma, Chronic Obstructive Pulmonary Disease
Phase 4TerminatedVA Office of Research and Development252013-03-122020-02-05
FAST as a Treatment for Obstructive Sleep Apnea
Encore Tongue Suspension System - Obstructive Sleep Apnea
Phase 4TerminatedSiesta Medical, Inc.52012-05-012017-02-24
Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children
Montelukast - Obstructive Sleep Apnea
Phase 4TerminatedUniversity of Chicago642010-07-012019-05-03
Burden of Obstructive Sleep Apnea in Stroke (BOSAST)
CPAP, CPAP at sub-therapeutic pressure - Stroke, Obstructive Sleep Apnea
Phase 4TerminatedUniversity of California, San Diego32009-08-012016-04-04
Effects of Continuous Positive Airway Pressure (CPAP) in Heart Remodeling by Magnetic Resonance Imaging (MRI)
CPAP, No treatment - Obstructive Sleep Apnea
Phase 4TerminatedUniversity of Sao Paulo242007-07-012014-11-18
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
continuous positive airway pressure (CPAP), depot leuprolide plus estrogen/progestin replacement, pioglitazone - Polycystic Ovary Syndrome, Obstructive Sleep Apnea
Phase 4TerminatedUniversity of Chicago372003-09-012023-03-21

Narrower conditions

Sleep Apnea, Obstructive (12)  ·  Sleep Apnea Syndromes (2)  ·  Tonsillitis (2)  ·  Agnosia (1)  ·  Asthma (1)  ·  Cardiovascular Diseases (1)  ·  Delayed Emergence from Anesthesia (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Fatigue (1)  ·  Glucose Intolerance (1)  ·  Heart Failure (1)  ·  Hypoxia (1)  ·  Insulin Resistance (1)  ·  Metabolic Syndrome (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Apnea (12)  ·  Dyssomnias (12)  ·  Nervous System Diseases (12)  ·  Respiration Disorders (12)  ·  Respiratory Tract Diseases (12)  ·  Sleep Disorders, Intrinsic (12)  ·  Sleep Wake Disorders (12)  ·  Sleep Apnea Syndromes (10)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (3)  ·  Cardiovascular Diseases (2)  ·  Infections (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Pathologic Processes (2)  ·  Pharyngeal Diseases (2)

Interventions

Amlodipine (1)  ·  Continuous Positive Airway Pressure (1)  ·  Dexmedetomidine (1)  ·  Drug Delivery Systems (1)  ·  Estrogens (1)  ·  Ibuprofen (1)  ·  Leuprolide (1)  ·  Modafinil (1)  ·  Pioglitazone (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Valsartan (1)  ·  acetaminophen, hydrocodone drug combination (1)  ·  montelukast (1)  ·  oxycodone-acetaminophen (1)

Sponsors

University of Chicago (2)  ·  University of Sao Paulo (2)  ·  Emory University (1)  ·  Inspire Medical Systems, Inc. (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Milton S. Hershey Medical Center (1)  ·  Siesta Medical, Inc. (1)  ·  University Hospital, Grenoble (1)  ·  University of California, San Diego (1)  ·  VA Office of Research and Development (1)

Countries

United States (8)  ·  Brazil (2)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)

Top investigators

Andrew Goldberg, MD (1)  ·  Armin Steffen, PD Dr. med. (1)  ·  Clemens Heiser, Dr. med. (1)  ·  David A Ehrmann, M.D. (1)  ·  Esra Tasali, M.D. (1)  ·  Eve Van Cauter, Ph.D. (1)  ·  Joachim T Maurer, OA Dr. med. (1)  ·  Joel Dimsdale, MD (1)  ·  Leila Gozal, MD (1)  ·  Luciano F Drager, MD, PhD (1)  ·  Makara Cayer, MD (1)  ·  Mihaela Teodorescu, MD (1)  ·  Olivier Vanderveken, Prof. dr. (1)  ·  Renaud RT Tamisier, PhD (1)  ·  Roy Rajan, MD (1)

Results publications

PMID 18172212, PMID 18647805, PMID 21123449, PMID 23019248

NIH funding

R01HL075079 (1)